Home

Schauspiel Slipper Einfach achim aigner leipzig university germany Ablehnung Tanker Rückerstattung

Perspectives, issues and solutions in RNAi therapy: the expected and the  less expected
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig -  ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

Nanoparticle-mediated delivery of small RNA molecules in tumor therapy
Nanoparticle-mediated delivery of small RNA molecules in tumor therapy

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP)  knockdown in colon carcinoma – topic of research paper in Biological  sciences. Download scholarly article PDF and read for free on CyberLeninka  open science
Anti-tumor effects of fibroblast growth factor-binding protein (FGF-BP) knockdown in colon carcinoma – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open science

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

Let Life Sciences meet you Let Life Sciences meet you
Let Life Sciences meet you Let Life Sciences meet you

MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma  Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma  Industry and MedTech | | Pharma Industry and MedTech Congress
MedTech-2022 Conferences | MedTech -2022 | MedTech 2022 Events | Pharma Industry and MedTech | MedTech Conferences | MedTech Meetings | Pharma Industry and MedTech | | Pharma Industry and MedTech Congress

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and  Myocardin-Related Transcription Factors (MRTFs), Con
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer  Cells In Vitro and In Vivo
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo

European Technology Platform on Nanomedicine
European Technology Platform on Nanomedicine

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas -  Academia.edu
PDF) The proto-oncogene Pim-1 is a target of miR-33a | Marshall Thomas - Academia.edu

Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 |  Conferenceseries
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Analysis of cellular and molecular antitumor effects upon inhibition of  SATB1 in glioblastoma cells
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s  (OM-PEIs) for in Vivo Gene Delivery
Biocompatibility and Efficacy of Oligomaltose-Grafted Poly(ethylene imine)s (OM-PEIs) for in Vivo Gene Delivery

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology